Alopecia Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030
The Global Alopecia Market Size accounted for USD 8,379 Million in 2021 and is estimated to achieve a market size of USD 16,760 Million by 2030 growing at a CAGR of 8.2% from 2022 to 2030. Sedentary lifestyles with poor diets, as well as the increasing prevalence of areata and androgenic alopecia around the world, are the key drivers driving the global alopecia market growth. Furthermore, the increased incidences of hair loss, as well as technological developments in alopecia treatments, are propelling the global alopecia market value.
Alopecia Market Report Key Highlights
- Global alopecia market revenue is expected to increase by USD 16,760 Million by 2030, with a 8.2% CAGR from 2022 to 2030
- North America region led with more than 36% of alopecia market share in 2021
- Asia-Pacific alopecia motor market growth will observe strongest CAGR from 2022 to 2030
- By disease type, the alopecia areata segment has accounted market share of over 35% in 2021
- By distribution channel, prescription segment engaged more than 66% of the total market share in 2021
- Rising alopecia prevalence on a global scale, drives the alopecia market size
Alopecia refers to the loss of hair from parts of the head or body. A sedentary lifestyle and unhealthy diets are leading loss of hair among the masses. Hormonal miss proportion and aging contribute to rising cases of hair loss. The overall rise in the geriatric population and rising awareness and preference for surgical hair transplants and other such treatments also have a positive influence on the global market in the forecast period.
Global Alopecia Market Trends
Market Drivers
- Rising alopecia prevalence on a global scale
- Increase in global health spending
- Growing incidence of chronic diseases
- Technological advancements in alopecia therapy
Market Restraints
- A lack of reimbursement rules for alopecia treatment
- Rising adoption of alternatives
Market Opportunities
- Adoption of innovative technologies in the treatment of alopecia
- Increasing number of proposals are being performed by organizations
Alopecia Market Report Coverage
| Market | Alopecia Market |
| Alopecia Market Size 2021 | USD 8,379 Million |
| Alopecia Market Forecast 2030 | USD 16,760 Million |
| Alopecia Market CAGR During 2022 - 2030 | 8.2% |
| Alopecia Market Analysis Period | 2018 - 2030 |
| Alopecia Market Base Year | 2021 |
| Alopecia Market Forecast Data | 2022 - 2030 |
| Segments Covered | By Disease Type, By Distribution Channel, By End Users, And By Geography |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | Cipla, Dr. Reddy’s Laboratories Ltd, Merck & Co., Viviscal, Regaine, Ranbaxy Laboratories Ltd, Kirkland Signature, Lexington International LLC, Vitabiotics, Alpecin - Dr. Kurt Wolff GmbH & Co, Johnson and Johnson, and GlaxoSmithKline PLC. |
| Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Product developments are expected to drive market growth in the near future. Recent product development such as the introduction of rapidly acting JAK drugs approved by the U.S. Food and Drug Administration (FDA), developments of methods to stimulate hair growth using human pluripotent stem cells, development of PRP treatment, the introduction of a new drug SM04554 which Specifically which stimulate hair growth in men are driving factors. Technological advancements and products like Hairmax Laser Comb, Follinex Massager Comb, Lifemax Infrared Hair Brush and Hair Growth Renewing lasers are some of the products built on advanced technology. The launch of new drugs and the treatment success rate and the clinical outcomes are some of the biggest drives.
The global alopecia market is segmented on the basis of types, end users, and distribution channels. On the basis of disease type, the global market is segmented into alopecia areata and androgenetic alopecia. On the basis of end users, the market is segmented into homecare settings, dermatology clinics, and others. And on the basis of distribution channels, the market is categorized into prescriptions and OTC.
Alopecia Market Segmentation
The global alopecia market segmentation is based on disease type, distribution channel, end users, and geography.
Alopecia Market By Disease Type
- Alopecia Areata
- Androgenetic Alopecia
- Cicatricial Alopecia
- Alopecia Universalis
- Alopecia Totalis
- Traction Alopecia
- Other
According to an alopecia industry analysis, the alopecia areata disease type segment held a considerable market share in 2021. This expansion is being driven by increasing disease incidence and rising consumer consciousness among sufferers. The segment is expected to rise at a rapid pace during the projected period, due to a surge in the creation of novel therapies and positive measures in the regulatory process. The increasing disease frequency around the world, as well as increased consumer awareness about therapies, are driving expansion. Furthermore, baldness is more common in persons who have autoimmune illnesses. Moreover, due to the emergence of numerous potential pipeline prospects and strong growth in the estimated incidence, the androgenetic alopecia segment is predicted to develop at the fastest rate.
Alopecia Market By Distribution Channel
- Prescriptions
- OTC
In terms of distribution channels, the prescription segment leads the global alopecia market in 2021. Various factors supporting segment expansion include cost-effective therapy, convenient access to medicines, and a growing amount of drug approvals. Furthermore, a solid product portfolio, rising discretionary income, and the increased incidence of chronic conditions that cause hair loss are likely to drive the segment's quickest growth throughout the projection period.
Alopecia Market By End Users
- Homecare Settings
- Dermatology Clinics
- Other
According to the alopecia market forecast, the dermatology clinics segment led the global market and contributed to the largest revenue portion over the projected timeframe. Dermatology clinics hire experienced specialist doctors who are trained to diagnose scalp and hair problems. Dermatologists can help determine the root cause of hair problems and efficiently cure hair fall in a variety of situations. Dermatology centers have a sizable share of the market due to the growing number of treatments associated with hair restoration and reinstatement, as well as the extensive use of prescription medications. Health centers have the knowledge to both prevent and encourage hair growth.
Alopecia Market Regional Outlook
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
North America Dominates The Global Alopecia Market
Geographically, North America leads the market and is expected to grow lucratively over the forecast period. The presence of technologically advanced healthcare infrastructure, High disposable income, and availability of novel therapeutic options affecting the treatment are some of the factors contributing to the high market share of North America.
Moreover, Europe is expected to dominate in the near future owing to the outburst of the middle-aged population. Asia Pacific has also witnessed growth owing to a large population suffering from Alopecia and rising awareness affecting the available therapeutic options are the key drivers. Latin America, the Middle East, and Africa are expected to have sluggish growth. However, these regions are expecting healthy market growth owing to the huge opportunity for market growth.
Alopecia Market Players
Some of the top alopecia market companies offered in the professional report include Cipla, Dr. Reddy’s Laboratories Ltd, Merck & Co., Viviscal, Regaine, Ranbaxy Laboratories Ltd, Kirkland Signature, Lexington International LLC, Vitabiotics, Alpecin - Dr. Kurt Wolff GmbH & Co, Johnson and Johnson, and GlaxoSmithKline PLC.
Frequently Asked Questions
What is the size of global alopecia market in 2021?
The estimated value of global alopecia market in 2021 was accounted to be USD 8,379 Million.
What is the CAGR of global alopecia market during forecast period of 2022 to 2030?
The projected CAGR alopecia market during the analysis period of 2022 to 2030 is 8.2%.
Which are the key players operating in the market?
The prominent players of the global alopecia market are Cipla, Dr. Reddy’s Laboratories Ltd, Merck & Co., Viviscal, Regaine, Ranbaxy Laboratories Ltd, Kirkland Signature, Lexington International LLC, Vitabiotics, Alpecin - Dr. Kurt Wolff GmbH & Co, Johnson and Johnson, and GlaxoSmithKline PLC.
Which region held the dominating position in the global alopecia market?
North America held the dominating alopecia market during the analysis period of 2022 to 2030.
Which region registered the fastest growing CAGR for the forecast period of 2022 to 2030?
Asia-Pacific region exhibited fastest growing CAGR for alopecia market during the analysis period of 2022 to 2030.
What are the current trends and dynamics in the global alopecia market?
Rising alopecia prevalence on a global scale and increase in global health spending drives the growth of global alopecia market.
By distribution channel segment, which sub-segment held the maximum share?
Based on distribution channel, prescriptions output segment is expected to hold the maximum share of the alopecia market.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
